Sunday, Feb 28, 2021 | Last Update : 01:06 AM IST

Gilead

Health groups want India to rescind Gilead drug patents

Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.

15 May 2020 11:46 AM

Gilead's three-drug HIV regimen wins European panel approval

Biktarvy is once-daily tablet combining emtricitabine, tenofovir alafenamide and integrase inhibitor bictegravir.

30 Apr 2018 9:57 AM

Gilead triple HIV drug finds US FDA approval

However, rival ViiV Healthcare, quickly filed a lawsuit alleging that Gilead was infringing patents on ViiV’s dolutegravir.

08 Feb 2018 9:54 AM

ADVERTISEMENT
ADVERTISEMENT